WT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
BUY now. WT is pulling back (-2% regular session) right after a strong Q4 earnings beat and record AUM headline, while the broader trend remains bullish (stacked moving averages). With the stock near its key pivot/support zone (15.81) and analysts recently raising targets (17–19), the risk/reward favors entering immediately for an impatient buyer, despite hedge-fund selling and mixed options volume signals.
Trend is still bullish: SMA_5 > SMA_20 > SMA_200 confirms an uptrend/positive structure. Momentum is cooling but not broken—MACD histogram is above zero (0.129) yet contracting, consistent with a short-term digestion after a run. RSI(6)=61.18 is neutral-to-slightly-bullish (not overbought). Key levels: Pivot/support at ~15.81 is the first “line in the sand”; a hold above it keeps the uptrend intact. Near-term resistance sits at R1 ~16.89, then R2 ~17.56 (aligns with raised price targets). Intellectia Proprietary Trading Signals: - AI Stock Picker: No signal on given stock today. - SwingMax: No signal on given stock recently.
Q4 2025 results beat expectations: non-GAAP EPS $0.29 vs $0.23 est; revenue $147.4M (+33.2% YoY).
Record AUM of $144.5B and improved operating metrics (operating margin reported up to 40.5%).
Product/innovation catalyst: expansion of tokenized funds to Solana could broaden distribution and brand relevance in digital assets.
Recent analyst upgrades/target raises (Oppenheimer to $17, Northland to $
provide supportive “Wall Street bid.”
Hedge funds are selling (reported selling amount up sharply QoQ), a near-term sentiment/positioning headwind.
Options tape is mixed: despite bullish call-heavy open interest, the day’s volume is put-dominated (near-term caution/hedging).
Technical momentum is easing (MACD contracting) and price just sold off after earnings—could continue to consolidate before pushing higher.
The provided snapshot shows gross margin dropped to 0 (-100% YoY), which is either an accounting/data anomaly or a real red flag; if real, it would conflict with the otherwise-strong profitability narrative.
Latest quarter: 2025/Q4. Growth was strong: revenue $135.421M (+22.33% YoY), net income $41.235M (+57.37% YoY), EPS $0.29 (+61.11% YoY). This indicates accelerating profitability versus revenue growth (operating leverage). Note: the dataset flags gross margin at 0 (down 100% YoY), which does not align with the strong earnings/margin headlines; treating that specific gross-margin datapoint as questionable, the broader quarter performance reads as clearly positive.
Recent trend: analyst price targets have moved up overall in late Jan 2026. Oppenheimer raised PT to $17 (Outperform) citing strong AUM growth and undervaluation; Northland raised PT to $19 (Outperform) citing strong start to 2026. Offsetting context: Morgan Stanley remains Equal Weight (PT $14.75) and previously flagged softer flows; Goldman previously cut PT to $13.25 (Neutral). Wall Street pros: accelerating AUM/revenue, earnings beat, and perceived undervaluation with raised targets. Cons: flow sensitivity and mixed coverage with some neutrals, plus potential volatility around market levels/asset manager sentiment. Politicians/influential figures: no congress trading data available in the last 90 days.
